Modulators of P-glycoprotein-associated multidrug resistance
- PMID: 1686715
- DOI: 10.1007/978-1-4615-3872-1_7
Modulators of P-glycoprotein-associated multidrug resistance
Similar articles
-
Clinical implications of multidrug resistance to chemotherapy.Cancer Treat Res. 1991;57:171-86. doi: 10.1007/978-1-4615-3872-1_8. Cancer Treat Res. 1991. PMID: 1686716 Review. No abstract available.
-
Reversal of multidrug resistance.Cancer Treat Rev. 1990 Dec;17 Suppl A:37-43. doi: 10.1016/0305-7372(90)90014-7. Cancer Treat Rev. 1990. PMID: 1982642 Review. No abstract available.
-
Specific inhibitors distinguish the chloride channel and drug transporter functions associated with the human multidrug resistance P-glycoprotein.Recept Channels. 1993;1(4):305-13. Recept Channels. 1993. PMID: 7915949
-
The role of P-glycoprotein in drug-resistant hematologic malignancies.Cancer Treat Res. 1991;57:187-208. doi: 10.1007/978-1-4615-3872-1_9. Cancer Treat Res. 1991. PMID: 1686717 Review. No abstract available.
-
Multidrug resistance: molecular biology and clinical relevance.J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907. J Natl Cancer Inst. 1989. PMID: 2567355 No abstract available.
Cited by
-
Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.Tumour Biol. 2012 Aug;33(4):943-56. doi: 10.1007/s13277-012-0323-5. Epub 2012 Jan 31. Tumour Biol. 2012. PMID: 22290425
-
Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers.Pharm Res. 2000 May;17(5):533-8. doi: 10.1023/a:1007508714259. Pharm Res. 2000. PMID: 10888304
-
Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.Cytotechnology. 1998 Sep;27(1-3):113-36. doi: 10.1023/A:1008052401952. Cytotechnology. 1998. PMID: 19002787 Free PMC article.